Hong Kong’s planned SPAC rules could give it an edge in attracting Chinese tech, biotech firms
- SPACs have raised more than US$126 billion globally this year
- Planned listing changes in Hong Kong may require fine-tuning, deal makers say

The so-called blank-cheque companies have been one of the hottest fundraising trends globally over the past 18 months, raising US$126.4 billion this year and accounting for more than half of the capital raised in IPOs on American bourses, according to SPAC Analytics, a research firm focused on the investment vehicles.

03:34
SPACs: Everything you need to know about the finance world’s new big thing
“For mainland companies, Hong Kong has long been their first choice for listing outside the domestic market as it is an international financial centre that shares the same language and culture with China,” said Louis Lau, a partner in the capital markets advisory group at KPMG China. “When Hong Kong allows SPACs to list here, it is natural that a majority of mainland companies will opt for a listing in Hong Kong, instead of going to the US.”